Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 36,519 | 28,418 | 61,990 | 21,272 | 17,392 |
| Cost of Goods | 8,986 | 529 | 2,225 | 907 | 4,844 |
| Gross Profit | 27,533 | 27,889 | 59,765 | 20,365 | 12,548 |
| Operating Expenses | 37,998 | 41,061 | 36,196 | 38,411 | 39,095 |
| Operating Income | -9,479 | -12,643 | 23,794 | -17,139 | -25,703 |
| Interest Expense | 3,014 | 3,011 | 3,136 | 3,106 | 2,982 |
| Other Income | 1,417 | 1,105 | 43,874 | 868 | 1,285 |
| Pre-tax Income | -11,076 | -14,549 | 64,532 | -19,377 | -27,400 |
| Net Income Continuous | -11,076 | -14,549 | 64,532 | -19,377 | -27,400 |
| Net Income | $-11,076 | $-14,549 | $64,532 | $-19,377 | $-27,400 |
| EPS Basic Total Ops | -0.20 | -0.26 | 1.17 | -0.32 | -0.52 |
| EPS Basic Continuous Ops | -0.20 | -0.26 | 1.17 | -0.31 | -0.52 |
| EPS Diluted Total Ops | -0.20 | -0.26 | 1.06 | -0.32 | -0.52 |
| EPS Diluted Continuous Ops | -0.20 | -0.26 | 1.01 | -0.31 | -0.52 |
| EBITDA(a) | $-5,603 | $-8,846 | $27,567 | $-12,825 | $-22,047 |